Joe Menzin, PhD

Joseph Menzin, Ph.D. is the CEO of BHE, a health analytics research firm that he founded in 1996. He has more than 30 years of experience in the fields of outcomes research, epidemiology, and informatics. Dr. Menzin spearheaded the development and launch of BHE’s flagship analytics platforms.  He has authored several dozen papers in medical, pharmacy, and outcomes research journals across a wide range of subjects from clinical trials to program evaluation. He serves as a reviewer for numerous journals, and is a member of many professional associations. Dr. Menzin has a Bachelor’s degree in Economics from the University of Rochester and earned his doctorate in Economics from Boston University.

Panalgo News

BHE is Now Panalgo: Why We Changed Our Name and Brand

In 1996, I started Boston Health Economics (BHE) to provide professional research services to the life sciences industry, including economic modeling, database analyses and strategic consulting. For more than two decades we have had the privilege of serving the industry’s leading life sciences organizations.

ihduserconference-3-300x192
Conferences and Events

Instant Health Data User Conference Showcases Customer-Driven Applications of Real-World Evidence

BHE held its 2018 Instant Health Data (IHD) User’s Conference on Wednesday, March 14th at the Ritz Carlton Hotel in Philadelphia, Pennsylvania. Real-world evidence (RWE) managers and IHD users attended from over a dozen life science companies and payers, representing about one-half of all companies licensing IHD. These researchers regularly use[…]

Drug Pricing

Policy Corner: The Mysterious World of Drug Pricing

Almost every day, I see unflattering news stories regarding drug pricing and the cost of pharmaceuticals. Whether it's a supplier raising the costs of essential drugs like the Epi-Pen several-fold or a new CAR-T drug priced at a seemingly exorbitant rate - not unlike a three-bedroom house here in the Boston area - media and government scrutiny is[…]

ICER

Big Changes for HEOR in 2017

As we make our way through the first quarter of 2017, there are a lot of exciting changes happening in the field of health economics and outcomes research (HEOR) that may have important implications for how researchers generate and disseminate evidence.

Instant Health Data

Put reliable, rapid analytics in the hands of more people across your organization

Learn more about Panalgo

Get the story behind our work and our team.